PhD-defense: Gry Sandvik Haaland
Gry Sandvik Haaland defends her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin mediated inhibition of the receptor tyrosine kinase AXL”
Main content
UNIVERSITY OF BERGEN
FACULTY OF MEDICINE
DOCTORAL DISSERTATION DEFENCE
Gry Sandvik Haaland
Trial lecture: Friday 17. November 2017 at 10.15
Given topic “The Role of Cancer-associated Fibroblasts (CAFs) in Tumour Progression”
Defence: Friday 17. November 2017 kl. 12.15
Dissertation: “Investigations of the cancer therapeutic and protective effects of warfarinmediated inhibition of the receptor tyrosine kinase AXL”
1st opponent: Ph.d. Sassan Hafizi, University of Portsmouth, UK
2nd opponent: Professor Kristin A. Taskén, Oslo University Hospital
3rd member of the Committee: Professor Linda Elin Birkhaug Stuhr, Universitety og Bergen
The defence will be led by Boleslaw Srebro
The public is invited
Candidate from Department of Biomedicine
Main supervisor: Professor James B. Lorens
Co-supervisor: Ph.d. Oddbjørn Straume
